NEUROLOGY 2004;62:226-233
© 2004 American Academy of Neurology
Spinal cord abnormalities in recently diagnosed MS patients
Added value of spinal MRI examination
J. C.J. Bot, MD,
F. Barkhof, MD, PhD,
C. H. Polman, MD, PhD,
G.J. Lycklama à Nijeholt, MD, PhD,
V. de Groot, MD,
E. Bergers, MD, PhD,
H. J. Ader, PhD and
J. A. Castelijns, MD, PhD
From the MR Center for MS Research, Departments of Radiology (Drs. Bot, Barkhof, Lycklama à Nijeholt, Bergers, and Castelijns), Neurology (Dr. Polman), Rehabilitation Medicine (Dr. de Groot), Biostatistics and Epidemiology (Dr. Ader), "Vrije Universiteit" Medical Center, Amsterdam, The Netherlands.
Address correspondence and reprint requests to Dr. Joost C.J. Bot, Department of Radiology, MR Center for MS Research, VU Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; e-mail: J.Bot{at}VUMC.nl
Objective: The most recent diagnostic criteria for multiple sclerosis (MS) ascertain that findings from spinal cord MRI can be used to demonstrate dissemination in space. Because little is known about the prevalence and characteristics of cord lesions early in the disease, the authors studied the prevalence of spinal cord abnormalities in patients with early-stage MS and assessed their impact on diagnostic classification.
Methods: The brains and spinal cords of 104 recently diagnosed patients with MS were examined. Median interval between first symptom and diagnosis was 18.4 months. The brain MRI protocol included before and after gadolinium axial T1-weighted conventional spin-echo sequences and dual-echo spin-echo images. For spinal cord MRI, sagittal cardiac-triggered dual-echo T2-weighted and sagittal T1-weighted spin-echo images were included. Clinical assessment for each patient included age, sex, clinical signs for spinal cord involvement, and Expanded Disability Status Scale.
Results: Abnormal cord MRIs were found in 83% of patients, usually with only focal lesions. Diffuse cord abnormalities were found in 13% of patients, although in isolation they were found in only three patients. Focal cord lesions were often multiple (median number, 3.0), small (median, 0.8 vertebral segments), and primarily (56.4%) situated in the cervical spinal cord. In 68 of 104 patients (65.4%), two or more focal lesions were visible on spinal cord images. The criteria for dissemination in space, as defined in the McDonald criteria for the brain, were met in only 66.3% of the patients. This percentage increased to 84.6% when spinal cord MRI abnormalities were also included.
Conclusion: Spinal cord abnormalities are prevalent in patients with early-stage MS, have distinct morphologic characteristics, and help to determine dissemination in space at time of diagnosis.
Received February 17, 2003.
Accepted in final form September 11, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
W Qiu, J-S Wu, M-N Zhang, T Matsushita, J-i Kira, W M Carroll, F L Mastaglia, and A G Kermode
Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database
J. Neurol. Neurosurg. Psychiatry,
February 1, 2010;
81(2):
209 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Swanton, K. Fernando, C. Dalton, K. Miszkiel, D. Altmann, G. Plant, A. Thompson, and D. Miller
Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis
Multiple Sclerosis,
February 1, 2010;
16(2):
156 - 165.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A.F. Marliani, V. Clementi, L. Albini Riccioli, R. Agati, M. Carpenzano, F. Salvi, and M. Leonardi
Quantitative Cervical Spinal Cord 3T Proton MR Spectroscopy in Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
January 1, 2010;
31(1):
180 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Sombekke, C. Lukas, J. B. A. Crusius, D. Tejedor, J. Killestein, D. Arteta, A. Martinez, B. M. J. Uitdehaag, D. L. Knol, A. S. Pena, et al.
HLA-DRB1*1501 and Spinal Cord Magnetic Resonance Imaging Lesions in Multiple Sclerosis
Arch Neurol,
December 1, 2009;
66(12):
1531 - 1536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakamura, H. Houzen, M. Niino, K. Tanaka, and H. Sasaki
Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan
Multiple Sclerosis,
December 1, 2009;
15(12):
1450 - 1458.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T Matsushita, N Isobe, T Matsuoka, N Shi, Y Kawano, X. Wu, T Yoshiura, Y Nakao, T Ishizu, and J. Kira
Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese
Multiple Sclerosis,
July 1, 2009;
15(7):
834 - 847.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Zackowski, S. A. Smith, D. S. Reich, E. Gordon-Lipkin, B. A. Chodkowski, D. R. Sambandan, M. Shteyman, A. J. Bastian, P. C. van Zijl, and P. A. Calabresi
Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord
Brain,
May 1, 2009;
132(5):
1200 - 1209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Osoegawa, J Kira, T Fukazawa, K Fujihara, S Kikuchi, M Matsui, T Kohriyama, G Sobue, T Yamamura, Y Itoyama, et al.
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years
Multiple Sclerosis,
February 1, 2009;
15(2):
159 - 173.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J-S Wu, M-N Zhang, W M Carroll, and A G Kermode
Characterisation of the spectrum of demyelinating disease in Western Australia
J. Neurol. Neurosurg. Psychiatry,
September 1, 2008;
79(9):
1022 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Liptak, A.M. Berger, M.P. Sampat, A. Charil, O. Felsovalyi, B.C. Healy, P. Hildenbrand, S.J. Khoury, H.L. Weiner, R. Bakshi, et al.
Medulla Oblongata Volume: A Biomarker of Spinal Cord Damage and Disability in Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
September 1, 2008;
29(8):
1465 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Minneboo, B Jasperse, F Barkhof, B M J Uitdehaag, D L Knol, V de Groot, C H Polman, and J A Castelijns
Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters
J. Neurol. Neurosurg. Psychiatry,
August 1, 2008;
79(8):
917 - 923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Rovaris, E Judica, A Ceccarelli, A Ghezzi, V Martinelli, G Comi, and M Filippi
Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study
Multiple Sclerosis,
July 1, 2008;
14(6):
853 - 856.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zwemmer, J. Bot, B. Jelles, F. Barkhof, and C. Polman
At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only
Multiple Sclerosis,
April 1, 2008;
14(3):
428 - 430.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zivadinov, A.C. Banas, V. Yella, N. Abdelrahman, B. Weinstock-Guttman, and M.G. Dwyer
Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis
AJNR Am. J. Neuroradiol.,
February 1, 2008;
29(2):
319 - 325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Poonawalla, P. Hou, F. A. Nelson, J. S. Wolinsky, and P. A. Narayana
Cervical Spinal Cord Lesions in Multiple Sclerosis: T1-weighted Inversion-Recovery MR Imaging with Phase-Sensitive Reconstruction
Radiology,
December 1, 2007;
246(1):
258 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inglese
Multiple sclerosis: new insights and trends.
AJNR Am. J. Neuroradiol.,
May 1, 2006;
27(5):
954 - 957.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, R Gordon, A J Thompson, and D H Miller
Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study
J. Neurol. Neurosurg. Psychiatry,
January 1, 2006;
77(1):
51 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H Polman, J. S Wolinsky, and S. C Reingold
Multiple sclerosis diagnostic criteria: three years later
Multiple Sclerosis,
February 1, 2005;
11(1):
5 - 12.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
Neurology,
December 14, 2004;
63(11_suppl_5):
S3 - S11.
[Abstract]
[Full Text]
|
 |
|
|